30.5.2007
•
News
M&A
KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Law firm Kocián Šolc Balaštík represented Indian pharmaceutical company Glenmark Pharmaceuticals Ltd. in concluding a deal via its Swiss subsidiary Glenmark Holding SA to acquire a majority shareholding in Medicamenta a.s., a company carrying out business activities in the production, sale and marketing of pharmaceutical products in the Czech Republic and Slovakia.
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
16.4.2026
•
News
Collaboration with World Bank on Analysis of Czech Business Environment
We would like to share that Kateřina Štěpánková has received a Certificate of Appreciation from World Bank in recognition of her contribution to the Subnational Business Ready in the European Union 2025 project, led by World Bank in cooperation with the European Commission (DG REGIO).
We would like to share that Kateřina Štěpánková has received a Certificate of Appreciation from World Bank in recognition of her contribution to the Subnational Business Ready in the European Union 2025 project, led by World Bank in cooperation with the European Commission (DG REGIO).
